Doctor profile · Federal record
Dr. Alvaro Restrepo, MD
Medical Oncology Physician (CMS: Medical Oncology) · McAllen, TX
- NPI 1992748586
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 39 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1901 S 2Nd St
McAllen, TX 785031271
(956) 687-5150
fax (956) 687-9546 - Mailing address
-
Po Box 911230
Dallas, TX 753920001
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- May 8, 2008
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #L3093
- Medicaid (2)
- TX #150865703 · TX #150865702
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1992748586. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
12,020
Distinct HCPCS
10
Medicare allowed
$143,333
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 8,160 | 11 | $1 | |
36415 |
Insertion of needle into vein for collection of blood sample | 475 | 197 | $8 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 459 | 196 | $8 | |
80053 |
Blood test, comprehensive group of blood chemicals | 454 | 196 | $10 | |
83615 |
Lactate dehydrogenase (enzyme) level | 437 | 195 | $6 | |
83735 |
Magnesium level | 429 | 186 | $7 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 394 | 218 | $122 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 193 | 15 | $0 | |
83540 |
Iron level | 147 | 118 | $6 | |
82728 |
Ferritin (blood protein) level | 146 | 118 | $13 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 1,175. This provider delivers 10× the peer median.Open Payments
Industry payments received
All-time total
$469
Transactions
16
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 2 | $162.28 | |
| Gilead Sciences, Inc. | 2 | $54.84 | |
| Daiichi Sankyo Inc. | 2 | $36.40 | |
| Tempus AI, Inc | 1 | $26.95 | |
| Eisai Inc. | 1 | $25.89 | |
| Karyopharm Therapeutics Inc. | 1 | $24.41 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $23.70 | |
| Medtronic, Inc. | 1 | $23.46 | |
| GlaxoSmithKline, LLC. | 1 | $21.80 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21.28 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $18.02 | |
| Novartis Pharmaceuticals Corporation | 1 | $17.00 | |
| Aveo Pharmaceuticals, Inc. | 1 | $13.13 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
957
Patients
159
Total drug cost
$1,804,780
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 403 | 96 | $11,255 |
| Prednisone | Generic | 67 | 11 | $382 |
| Dexamethasone | Generic | 60 | 24 | $828 |
| Imatinib Mesylate | Generic | 59 | 0 | $82,836 |
| Levothyroxine Sodium | Generic | 50 | 15 | $670 |
| Tamoxifen Citrate | Generic | 42 | 13 | $2,046 |
| Imbruvica (Ibrutinib) | Brand | 40 | 0 | $457,721 |
| Abiraterone Acetate | Generic | 39 | 0 | $121,639 |
| Everolimus | Generic | 38 | 0 | $297,269 |
| Hydroxyurea | Generic | 35 | 0 | $1,746 |
Hospital affiliations
Frequently asked questions
What is Dr. Alvaro Restrepo's medical specialty?
Dr. Alvaro Restrepo practices Medical Oncology Physician in McAllen, TX.
Where does Dr. Alvaro Restrepo practice?
Dr. Alvaro Restrepo practices at 1901 S 2Nd St, McAllen, TX 785031271. Office phone: 9566875150.
What is Dr. Alvaro Restrepo's NPI?
Dr. Alvaro Restrepo's National Provider Identifier (NPI) is 1992748586, issued by NPPES.
Does Dr. Alvaro Restrepo accept Medicare assignment?
Yes. Dr. Alvaro Restrepo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Alvaro Restrepo commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Insertion of needle into vein for collection of blood sample (HCPCS 36415); Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS 85025). Source: CMS Medicare Physician & Other Practitioners file.